IndraLab

Statements


PAN2 inhibits AKT. 2 / 2
| 2

reach
"This study demonstrates that USP52 inhibits cancer cell proliferation through downregulation of cyclin D1 as well as AKT/mTOR signaling pathway inhibition."

reach
"In a similar vein, Zhu et al. demonstrated that USP52 stabilizes PTEN, downregulates cyclin D1, and inhibits the AKT/mTOR pathway, thereby suppressing cancer cell proliferation (41)."